CE Unterberg Towbin initiates coverage on Rosetta Genomics, Ltd. (Nasdaq: ROSG) with a Buy rating and $12 price ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE